Five months after UFC light heavyweight Roman Dolidze (6-0 MMA, 0-0 UFC) was flagged by the U.S. Anti-Doping Agency for a positive test, the Ukrainian has accepted a one-year suspension.

The undefeated fighter was scheduled twice since signing with the promotion earlier this year, but withdrew from both bouts. First, Doldize was scheduled to take on Gadzhimurad Antigulov at UFC on ESPN+ 7 in April. Then, Dolidze was rebooked against Vinicius Moreira at UFC on ESPN 3 in June.

Friday, USADA announced Dolidze “tested positive for clomiphene and its metabolites M1 and M2, as well as a long-term metabolite of dehydrochlormethlytestosterone (DHCMT), 4-chloro-18-nor-17β-hydroxymethyl, 17α-methyl-5α-androst-13-en-3α-ol (M3).”

The flagged sample stemmed from a urine test conducted out-of-competition on March 12. According to USADA, “Clomiphene is a Specified Substance in the category of Hormone and Metabolic Modulators, while DHCMT is a non-Specified Substance in the class of Anabolic Agents. Both substances are prohibited at all times under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency (WADA) Prohibited List.”

USADA’s release also stated Dolidze’s transparency and cooperation throughout the entire process led to a reduced sentence.

“Dolidze immediately came forward with detailed evidence of his use of prohibited substances before entering the UFC Anti-Doping Program and continued to cooperate throughout USADA’s investigation related to his use,” the report said.